These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10498657)

  • 1. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.
    Christie JM; Chapel H; Chapman RW; Rosenberg WM
    Hepatology; 1999 Oct; 30(4):1037-44. PubMed ID: 10498657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion of activated immune cells induced fluctuations of HCV titer without mutations in hepatitis C virus core and E2 region CTL epitopes].
    Wang Q; Chen H; Cong X; Fei R; Gao Y; Sun J; Wei L; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):329-32. PubMed ID: 12665897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients.
    Booth JC; Kumar U; Webster D; Monjardino J; Thomas HC
    Hepatology; 1998 Jan; 27(1):223-7. PubMed ID: 9425941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection.
    Wang H; Bian T; Merrill SJ; Eckels DD
    J Mol Evol; 2002 Apr; 54(4):465-73. PubMed ID: 11956685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects.
    Gaud U; Langer B; Petropoulou T; Thomas HC; Karayiannis P
    J Med Virol; 2003 Mar; 69(3):350-6. PubMed ID: 12526045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
    Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
    Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O; Lasarte JJ; Wilkinson G; Grace K; Clarke B; Borrás-Cuesta F; Prieto J
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral escape from humoral immune system by mutations in hypervariable region of HCV envelope protein and mechanism of persistent viral infection].
    Kato N; Nakazawa T; Sekiya H; Mizutani T; Shimotohno K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):129-35. PubMed ID: 7563673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
    Nakazawa T; Hijikata M; Kato N; Shimotohno K
    Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
    Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
    J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.